Clinical Trials Directory

Trials / Unknown

UnknownNCT03990675

Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids

Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids Generated From Matched Fine Needle Aspirations (FNA) and Fine Needle Biopsies (FNB)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Technical University of Munich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive forms of cancer. Despite advances in the understanding of the mechanisms underlying PDAC pathogenesis, the impact on patient benefit is lagging. As a result, new model systems are being developed and used to fill this gap with the hope of translation into improved diagnostics and therapeutics. Organoids represent a powerful tool for research with the capacity to be applied to many key aspects of pancreatic tissue pathology. 3D organoids can be generated from endoscopic fine-needle aspiration or fine needle biopsy samples. In this study, we will evaluate and compare the growth rate of pancreatic cancer patient-derived organoids generated from matched fine needle Aspirations (FNA) and fine needle biopsies (FNB).

Conditions

Interventions

TypeNameDescription
PROCEDUREFNA, FNBEndoscopic ultrasound guided fine needle aspiration, Endoscopic ultrasound guided fine needle biopsy

Timeline

Start date
2018-12-01
Primary completion
2021-08-01
Completion
2022-08-01
First posted
2019-06-19
Last updated
2019-06-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03990675. Inclusion in this directory is not an endorsement.